Rising Drug Development Activities drive growth of Hypophosphatasia Treatment Market
Hypophosphatasia is a rare, inherited disorder that impairs the body's ability to mineralize bones. The hypophosphatasia treatment products mainly includes drug therapies and bone grafting procedures. The major drugs used for hypophosphatasia treatment include asfotase alfa, bone morphogenetic proteins, and calcium and vitamin D supplements. These drugs help in improving bone mineralization and...
0 Comments 0 Shares 28 Views 0 Reviews
Sponsored